Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer

It has been shown that a 4-bp insertion/deletion (ins/del) polymorphism of EGLN2 influences the risk of several cancers. However, to date, no study has inspected the impact of the 4-bp ins/del polymorphism on breast cancer (BC) risk. A case-control study, including 134 breast cancer patients and 154...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemi, Mohammad, Danesh, Hiva, Bizhani, Fatemeh, Sattarifard, Hedieh, Hashemi, Seyed Mehdi, Bahari, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031807/
https://www.ncbi.nlm.nih.gov/pubmed/29693343
http://dx.doi.org/10.22034/APJCP.2018.19.4.923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031807/
https://www.ncbi.nlm.nih.gov/pubmed/29693343
http://dx.doi.org/10.22034/APJCP.2018.19.4.923

Ejemplares similares